Why the global biomaterials ecosystem needs a major rethink

The biomaterials manufacturing ecosystem is broken. Life-changing medical treatments rely on biomaterials, but prices are excessive, access is limited, and a handful of global players control the supply. Innovation is stifled, and patients pay the price.

Imagine if you could make the cost of research-grade biomaterials more affordable; research institutes would experience a renaissance of life-saving breakthroughs.